Viewing Study NCT00198367


Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2026-01-29 @ 5:10 PM
Study NCT ID: NCT00198367
Status: COMPLETED
Last Update Posted: 2019-05-28
First Post: 2005-09-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC)
Sponsor: Hospices Civils de Lyon
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None operable and resectable stage IIIA (T1-3, N2) NSCLC View